Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taavi K Neklesa

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular and Cellular Endocrinology|May 25, 2019
Targeting Nuclear Receptors with PROTAC degradersJohn J Flanagan, Taavi K Neklesa
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2008
Superoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complexTaavi K Neklesa, Ronald W Davis
Plos Genetics|June 13, 2009
A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complexTaavi K Neklesa, Ronald W Davis
Pharmacology & Therapeutics|February 23, 2017
Targeted protein degradation by PROTACsTaavi K Neklesa, James D Winkler, Craig M Crews
Chembiochem : a European Journal of Chemical Biology|January 25, 2012
Identification of hydrophobic tags for the degradation of stabilized proteinsHyun Seop Tae, Thomas B Sundberg, Taavi K Neklesa, et al.
Nature Chemical Biology|July 5, 2011
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteinsTaavi K Neklesa, Hyun Seop Tae, Ashley R Schneekloth, et al.
ACS Chemical Biology|August 28, 2013
A bidirectional system for the dynamic small molecule control of intracellular fusion proteinsTaavi K Neklesa, Devin J Noblin, Alexander P Kuzin, et al.
Communications Biology|October 2, 2018
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistanceJemilat Salami, Shanique Alabi, Ryan R Willard, et al.
Angewandte Chemie (International Ed. in English)|June 18, 2015
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic TaggingJeffrey L Gustafson, Taavi K Neklesa, Carly S Cox, et al.
Molecular Cancer Therapeutics|December 13, 2024
Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor DegraderLawrence B Snyder, Taavi K Neklesa, Ryan R Willard, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular and Cellular Endocrinology|May 25, 2019
Targeting Nuclear Receptors with PROTAC degradersJohn J Flanagan, Taavi K Neklesa
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2008
Superoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complexTaavi K Neklesa, Ronald W Davis
Plos Genetics|June 13, 2009
A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complexTaavi K Neklesa, Ronald W Davis
Pharmacology & Therapeutics|February 23, 2017
Targeted protein degradation by PROTACsTaavi K Neklesa, James D Winkler, Craig M Crews
Chembiochem : a European Journal of Chemical Biology|January 25, 2012
Identification of hydrophobic tags for the degradation of stabilized proteinsHyun Seop Tae, Thomas B Sundberg, Taavi K Neklesa, et al.
Nature Chemical Biology|July 5, 2011
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteinsTaavi K Neklesa, Hyun Seop Tae, Ashley R Schneekloth, et al.
ACS Chemical Biology|August 28, 2013
A bidirectional system for the dynamic small molecule control of intracellular fusion proteinsTaavi K Neklesa, Devin J Noblin, Alexander P Kuzin, et al.
Communications Biology|October 2, 2018
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistanceJemilat Salami, Shanique Alabi, Ryan R Willard, et al.
Angewandte Chemie (International Ed. in English)|June 18, 2015
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic TaggingJeffrey L Gustafson, Taavi K Neklesa, Carly S Cox, et al.
Molecular Cancer Therapeutics|December 13, 2024
Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor DegraderLawrence B Snyder, Taavi K Neklesa, Ryan R Willard, et al.
Pageof 2